No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Cardiac Resynchronization Therapy
-
Cardiotonic Agents / therapeutic use
-
Epigenomics / trends
-
Forecasting
-
Heart Failure / therapy*
-
Humans
-
Infusions, Intravenous
-
Iron / administration & dosage
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins / therapeutic use
-
Relaxin / therapeutic use
-
Renin-Angiotensin System / drug effects
-
Spironolactone / therapeutic use
-
Stroke Volume / physiology
-
Telemedicine / statistics & numerical data
-
Vagus Nerve Stimulation / statistics & numerical data
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Cardiotonic Agents
-
Mineralocorticoid Receptor Antagonists
-
Recombinant Proteins
-
serelaxin protein, human
-
Spironolactone
-
Relaxin
-
Iron